Neuropeptide Y (NPY) and the central nervous system: Distribution effects and possible relationship to neurological and psychiatric disorders

Claes R Wahlestedt, Rolf Ekman, Erik Widerlöv

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

1. NPY is a 36 amino acid tyrosine-rich peptide. It is one of the most abundant and widely distributed neuropeptides known today within the central nervous system with particularly high concentrations in the hypothalamus and in several limbic regions. 2. NPY seems to coexist with other on neurotransmitters like somatostatin, galanin, GABA and the catecholamines noradrenaline and adrenaline in discrete brain regions. 3. NPY binding sites are widely distributed in the brain. However they do not always overlap with the distribution of NPY-like inanunoreactivity. 4. NPY is suggested to be involved in a large number of neuroendocrine functions, stress responses, circadian rhythms, central autonomic functions, eating and drinking behaviour, and sexual and motor behaviour. 5. Psychotropic drugs and neurotoxins can alter the NPY concentrations in discrete brain regions. 6. It is possible that NPY is related to various neurological and psychiatric illnesses, like Huntington's chorea, Alzheimer's disease, Parkinson's disease, eating disorders, and major depressive illness.

Original languageEnglish
Pages (from-to)31-54
Number of pages24
JournalProgress in Neuropsychopharmacology and Biological Psychiatry
Volume13
Issue number1-2
DOIs
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

Neuropeptide Y
Nervous System Diseases
Psychiatry
Central Nervous System
Brain
Galanin
Drinking Behavior
Psychotropic Drugs
Huntington Disease
Neurotoxins
Feeding Behavior
Circadian Rhythm
Somatostatin
Neuropeptides
Sexual Behavior
gamma-Aminobutyric Acid
Epinephrine
Hypothalamus
Catecholamines
Neurotransmitter Agents

Keywords

  • Central nervous system
  • neurological diseases
  • neuropeptide Y
  • psychiatric disorders

ASJC Scopus subject areas

  • Biological Psychiatry
  • Pharmacology

Cite this

@article{1c6556288a154d2abd79c0375da85f04,
title = "Neuropeptide Y (NPY) and the central nervous system: Distribution effects and possible relationship to neurological and psychiatric disorders",
abstract = "1. NPY is a 36 amino acid tyrosine-rich peptide. It is one of the most abundant and widely distributed neuropeptides known today within the central nervous system with particularly high concentrations in the hypothalamus and in several limbic regions. 2. NPY seems to coexist with other on neurotransmitters like somatostatin, galanin, GABA and the catecholamines noradrenaline and adrenaline in discrete brain regions. 3. NPY binding sites are widely distributed in the brain. However they do not always overlap with the distribution of NPY-like inanunoreactivity. 4. NPY is suggested to be involved in a large number of neuroendocrine functions, stress responses, circadian rhythms, central autonomic functions, eating and drinking behaviour, and sexual and motor behaviour. 5. Psychotropic drugs and neurotoxins can alter the NPY concentrations in discrete brain regions. 6. It is possible that NPY is related to various neurological and psychiatric illnesses, like Huntington's chorea, Alzheimer's disease, Parkinson's disease, eating disorders, and major depressive illness.",
keywords = "Central nervous system, neurological diseases, neuropeptide Y, psychiatric disorders",
author = "Wahlestedt, {Claes R} and Rolf Ekman and Erik Widerl{\"o}v",
year = "1989",
month = "1",
day = "1",
doi = "10.1016/0278-5846(89)90003-1",
language = "English",
volume = "13",
pages = "31--54",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",
number = "1-2",

}

TY - JOUR

T1 - Neuropeptide Y (NPY) and the central nervous system

T2 - Distribution effects and possible relationship to neurological and psychiatric disorders

AU - Wahlestedt, Claes R

AU - Ekman, Rolf

AU - Widerlöv, Erik

PY - 1989/1/1

Y1 - 1989/1/1

N2 - 1. NPY is a 36 amino acid tyrosine-rich peptide. It is one of the most abundant and widely distributed neuropeptides known today within the central nervous system with particularly high concentrations in the hypothalamus and in several limbic regions. 2. NPY seems to coexist with other on neurotransmitters like somatostatin, galanin, GABA and the catecholamines noradrenaline and adrenaline in discrete brain regions. 3. NPY binding sites are widely distributed in the brain. However they do not always overlap with the distribution of NPY-like inanunoreactivity. 4. NPY is suggested to be involved in a large number of neuroendocrine functions, stress responses, circadian rhythms, central autonomic functions, eating and drinking behaviour, and sexual and motor behaviour. 5. Psychotropic drugs and neurotoxins can alter the NPY concentrations in discrete brain regions. 6. It is possible that NPY is related to various neurological and psychiatric illnesses, like Huntington's chorea, Alzheimer's disease, Parkinson's disease, eating disorders, and major depressive illness.

AB - 1. NPY is a 36 amino acid tyrosine-rich peptide. It is one of the most abundant and widely distributed neuropeptides known today within the central nervous system with particularly high concentrations in the hypothalamus and in several limbic regions. 2. NPY seems to coexist with other on neurotransmitters like somatostatin, galanin, GABA and the catecholamines noradrenaline and adrenaline in discrete brain regions. 3. NPY binding sites are widely distributed in the brain. However they do not always overlap with the distribution of NPY-like inanunoreactivity. 4. NPY is suggested to be involved in a large number of neuroendocrine functions, stress responses, circadian rhythms, central autonomic functions, eating and drinking behaviour, and sexual and motor behaviour. 5. Psychotropic drugs and neurotoxins can alter the NPY concentrations in discrete brain regions. 6. It is possible that NPY is related to various neurological and psychiatric illnesses, like Huntington's chorea, Alzheimer's disease, Parkinson's disease, eating disorders, and major depressive illness.

KW - Central nervous system

KW - neurological diseases

KW - neuropeptide Y

KW - psychiatric disorders

UR - http://www.scopus.com/inward/record.url?scp=0024601348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024601348&partnerID=8YFLogxK

U2 - 10.1016/0278-5846(89)90003-1

DO - 10.1016/0278-5846(89)90003-1

M3 - Article

C2 - 2664885

AN - SCOPUS:0024601348

VL - 13

SP - 31

EP - 54

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

IS - 1-2

ER -